Remove BioTech Remove Data Remove Life Science Remove Patient Experience
article thumbnail

EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate

Digital Health Global

EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of life science marketing. They are, however, fully owned and operated by EVERSANA.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. However, we are still missing the mark with patient involvement to make durable healthcare change towards a culture of patient centricity.

BioTech 107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bonus Features – November 20, 2022 – 90% of healthcare buyers prioritize virtual care but want a clear roadmap, wearable data helped predict COVID-19 infections 12 days before the CDC, and more

Healthcare IT Today

Another joint study, this one involving CareEvolution, Scripps Research, and The Rockefeller Foundation, concluded that data from wearable devices could forecast COVID-19 infection rates as many as 12 days earlier than CDC data alone. Engagement platform Twilio released a customer data platform for health and life sciences.

eCare 52
article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

.–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. It enables the delivery of traditional, hybrid and decentralised clinical trials while enhancing the patient experience.

article thumbnail

Digital Health Technologies in Clinical Trials

Digital Health Global

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. The use of DHTs in neurology trials produced consistent benefits on many levels.